Arcoma AB Valuation

ARCOMA Stock  SEK 7.82  0.22  2.89%   
At this time, the firm appears to be overvalued. Arcoma AB shows a prevailing Real Value of kr6.41 per share. The current price of the firm is kr7.82. Our model approximates the value of Arcoma AB from analyzing the firm fundamentals such as profit margin of 0.01 %, and Return On Equity of 0.0423 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
7.82
Please note that Arcoma AB's price fluctuation is somewhat reliable at this time. Calculation of the real value of Arcoma AB is based on 3 months time horizon. Increasing Arcoma AB's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Arcoma AB is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Arcoma Stock. However, Arcoma AB's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  7.82 Real  6.41 Hype  7.82
The real value of Arcoma Stock, also known as its intrinsic value, is the underlying worth of Arcoma AB Company, which is reflected in its stock price. It is based on Arcoma AB's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Arcoma AB's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
6.41
Real Value
9.10
Upside
Estimating the potential upside or downside of Arcoma AB helps investors to forecast how Arcoma stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Arcoma AB more accurately as focusing exclusively on Arcoma AB's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
5.137.8210.51
Details

About Arcoma AB Valuation

The stock valuation mechanism determines Arcoma AB's current worth on a weekly basis. Our valuation model uses a comparative analysis of Arcoma AB. We calculate exposure to Arcoma AB's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Arcoma AB's related companies.
Arcoma AB develops, produces, and provides radiology solutions worldwide. It offers digital x-ray and radiography systems for radiographic applications, as well as for use in general, eneral, muscleskeleton, thoratic, pediatric, and traumaresus clinics. Arcoma AB is traded on Stockholm Stock Exchange in Sweden.

8 Steps to conduct Arcoma AB's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Arcoma AB's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Arcoma AB's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Arcoma AB's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Arcoma AB's revenue streams: Identify Arcoma AB's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Arcoma AB's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Arcoma AB's growth potential: Evaluate Arcoma AB's management, business model, and growth potential.
  • Determine Arcoma AB's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Arcoma AB's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Complementary Tools for Arcoma Stock analysis

When running Arcoma AB's price analysis, check to measure Arcoma AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcoma AB is operating at the current time. Most of Arcoma AB's value examination focuses on studying past and present price action to predict the probability of Arcoma AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcoma AB's price. Additionally, you may evaluate how the addition of Arcoma AB to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.